AIRWAY SENSORY REPLACEMENT COMBINED WITH NICOTINE REPLACEMENT FOR SMOKING CESSATION - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL USING A CITRIC-ACID INHALER

被引:50
|
作者
WESTMAN, EC
BEHM, FM
ROSE, JE
机构
[1] DUKE UNIV,MED CTR,DEPT PSYCHIAT,DURHAM,NC
[2] VET ADM MED CTR,CTR HLTH SERV RES PRIMARY CARE,DURHAM,NC 27705
[3] DUKE UNIV,DIV GEN INTERNAL MED,DURHAM,NC
关键词
CITRIC ACID; NICOTINE PATCH; SMOKING CESSATION;
D O I
10.1378/chest.107.5.1358
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: This study was conducted to determine if the combination of airway sensory replacement and nicotine replacement improves 10-week smoking abstinence rates over nicotine replacement alone, Design: Double-blind, randomized, placebo-controlled trial. Setting: Outpatient research clinic, Participants: One hundred healthy volunteers who smoked at least one pack of cigarettes per day and desired to quit smoking, Interventions: Subjects received either citric acid (n=41) or lactose placebo (n=59) inhalers to cope with smoking urges for 10 weeks. All subjects received self-help materials and nicotine patches for 6 weeks, Return visits were at weeks 1, 4, 6, and 10, Abstinence was defined as zero cigarettes smoked since the quit date verified by exhaled carbon monoxide less than or equal to 8 ppm at ah return visits, Inhaler effects were measured by a standardized questionnaire. Measurements and results: The primary outcome of continuous abstinence at the end of the 10-week treatment period was 19.5% (95% confidence interval [CI]=7.4 to 31.6%) for the citric acid group vs 6.8% (95%, CI=0.4 to 13.2%) for the lactose group (p=0.05). Relief from craving and short-term abstinence increased as airway sensations from the inhaler also increased, Abstinence at 10 weeks for subjects receiving strong airway sensations from the inhalers was 33.3% (95%CI=14.5 to 52.1%). At 6 months, there was no difference in abstinence between the treatment groups (0% vs 5.1%, p=0.20). Conclusions: When combined with the nicotine patch, the citric acid inhaler improved 10-week smoking abstinence over lactose inhaler. The combination of airway sensory replacement and nicotine replacement may prove beneficial for smoking cessation.
引用
收藏
页码:1358 / 1364
页数:7
相关论文
共 50 条
  • [41] Genetic Variant inCHRNA5and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial
    Chen, Li-Shiun
    Baker, Timothy B.
    Miller, J. Philip
    Bray, Michael
    Smock, Nina
    Chen, Jingling
    Stoneking, Faith
    Culverhouse, Robert C.
    Saccone, Nancy L.
    Amos, Christopher, I
    Carney, Robert M.
    Jorenby, Douglas E.
    Bierut, Laura J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1315 - 1325
  • [42] Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation
    Perng, RP
    Hsieh, WC
    Chen, YM
    Lu, CC
    Chiang, SJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A735 - A735
  • [43] Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation
    Perng, RP
    Hsieh, WC
    Chen, YM
    Lu, CC
    Chiang, SJ
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (08) : 547 - 551
  • [44] EFFICACY OF A NICOTINE NASAL SPRAY IN SMOKING CESSATION - A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    SCHNEIDER, NG
    OLMSTEAD, R
    MODY, FV
    DOAN, K
    FRANZON, M
    JARVIK, ME
    STEINBERG, C
    ADDICTION, 1995, 90 (12) : 1671 - 1682
  • [45] Reducing Approach Bias to Achieve Smoking Cessation: A Pilot Randomized Placebo-Controlled Trial
    Baird, Scarlett O.
    Rinck, Mike
    Rosenfield, David
    Davis, Michelle L.
    Fisher, Jillian R.
    Becker, Eni S.
    Powers, Mark B.
    Smits, Jasper A. J.
    COGNITIVE THERAPY AND RESEARCH, 2017, 41 (04) : 662 - 670
  • [46] A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
    Rennard, Stephen
    Hughes, John
    Cinciripini, Paul M.
    Kralikova, Eva
    Raupach, Tobias
    Arteaga, Carmen
    St Aubin, Lisa B.
    Russ, Cristina
    NICOTINE & TOBACCO RESEARCH, 2012, 14 (03) : 343 - 350
  • [47] Gender differences in response to bupropion treatment in a randomized placebo-controlled smoking cessation trial
    Collins, B
    Wyleto, E
    Patterson, F
    Audrain-McGovern, J
    Hawk, L
    Kaufmann, V
    Pinto, A
    Niaura, R
    Epstein, L
    Lerman, C
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (02) : 181 - 181
  • [48] Reducing Approach Bias to Achieve Smoking Cessation: A Pilot Randomized Placebo-Controlled Trial
    Scarlett O. Baird
    Mike Rinck
    David Rosenfield
    Michelle L. Davis
    Jillian R. Fisher
    Eni S. Becker
    Mark B. Powers
    Jasper A. J. Smits
    Cognitive Therapy and Research, 2017, 41 : 662 - 670
  • [49] Clinical Effectiveness of Traditional and Complementary Medicine Interventions in Combination with Nicotine Replacement Therapy on Smoking Cessation: A Randomized Controlled Pilot Trial
    Jang, Soobin
    Lee, Ju Ah
    Jang, Bo-Hyoung
    Shin, Yong-Cheol
    Ko, Seong-Gyu
    Park, Sunju
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (05) : 526 - 534
  • [50] The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial
    Walker, Natalie
    Howe, Colin
    Bullen, Chris
    Grigg, Michele
    Glover, Marewa
    McRobbie, Hayden
    Laugesen, Murray
    Parag, Varsha
    Whittaker, Robyn
    ADDICTION, 2012, 107 (10) : 1857 - 1867